X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Abbott India Fact Sheet, Abbott India Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Abbott India Fact Sheet   (KNOL)

Here is the latest financial fact sheet of Abbott India. For more details, see the Abbott India quarterly results and Abbott India share price and chart. For a sector overview, read our pharmaceuticals sector report.

ABBOTT INDIA Price History

Price Rs 4,213.0
Mkt Cap Rs m 89,526
Vol '000 0.1
P/E X 32.4
P/CF X 32.7
EPS (TTM) Rs 130.2
% ch % -0.1
No. of shares m 21.25
% ch week % -4.3
% ch 1-mth % 5.1
% ch 12-mth % -6.1
52 week H/L Rs 5,190.0/3,996.0
(As on Jun 29, 2017 03:36:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ABBOTT INDIA Financials

No. of Mths
Year Ending
12
Dec-11
12
Dec-12
15
Mar-14
12
Mar-15
12
Mar-16
5-Yr Chart
Click to enlarge
ABBOTT INDIA EQUITY SHARE DATA
High Rs1,6831,8071,7934,1196,015 
Low Rs1,1781,3751,3003,7003,707 
Sales per share (Unadj.) Rs701.3777.71,080.91,077.31,236.9 
Earnings per share (Unadj.) Rs56.768.193.4107.7122.2 
Diluted earnings per shareRs56.768.193.4107.7122.2 
Cash flow per share (Unadj.) Rs63.777.3103.7114.8129.0 
Dividends per share (Unadj.) Rs17.0017.0023.0031.0035.00 
Adj. dividends per shareRs17.0017.0023.0031.0035.00 
Dividend yield (eoy) %1.21.11.50.80.7 
Book value per share (Unadj.) Rs256.0304.4370.8441.2521.2 
Adj. book value per shareRs256.0304.4370.8441.2521.2 
Shares outstanding (eoy) m21.2521.2521.2521.2521.25 
Bonus/Rights/Conversions  A---- 
Price / Sales ratio x2.02.01.43.63.9 
Avg P/E ratio x25.323.416.636.339.8 
P/CF ratio (eoy) x22.520.614.934.137.7 
Price / Book Value ratio x5.65.24.28.99.3 
Dividend payout %30.025.024.628.828.6 
Avg Mkt Cap Rs m30,39833,80932,85883,079103,296 
No. of employees `0002.42.72.82.93.0 
Total wages/salary Rs m1,6732,0622,9973,0543,370 
Avg. sales/employee Rs Th6,145.26,196.88,304.07,985.18,891.8 
Avg. wages/employee Rs Th689.9773.21,083.71,065.21,140.0 
Avg. net profit/employee Rs Th496.4542.6717.5798.6878.3 
ABBOTT INDIA INCOME DATA
Net Sales Rs m14,90216,52722,96922,89326,284 
Other income Rs m197223482476504 
Total revenues Rs m15,09916,75023,45123,36926,789 
Gross profit Rs m1,7552,0182,6833,1233,665 
Depreciation Rs m150195219149144 
Interest Rs m00158 
Profit before tax Rs m1,8022,0462,9463,4444,017 
Minority Interest Rs m00000 
Prior Period Items Rs m-430000 
Extraordinary Inc (Exp) Rs m0104000 
Tax Rs m5557039611,1541,421 
Profit after tax Rs m1,2041,4471,9852,2902,596 
Gross profit margin %11.812.211.713.613.9 
Effective tax rate %30.834.432.633.535.4 
Net profit margin %8.18.88.610.09.9 
ABBOTT INDIA BALANCE SHEET DATA
Current assets Rs m6,8637,7399,96512,26114,446 
Current liabilities Rs m2,3852,29630,6123,9694,725 
Net working cap to sales %30.032.9-89.936.237.0 
Current ratio x2.93.40.33.13.1 
Inventory Days Days6258576151 
Debtors Days Days3231172120 
Net fixed assets Rs m8001,0929951,0001,113 
Share capital Rs m212213213213213 
"Free" reserves Rs m5,1736,2007,6109,10710,808 
Net worth Rs m5,4416,4697,8799,37511,076 
Long term debt Rs m00000 
Total assets Rs m7,9139,07111,39213,73616,241 
Interest coverage xNM10,231.03,682.9689.7497.0 
Debt to equity ratio x00000 
Sales to assets ratio x1.91.82.01.71.6 
Return on assets %15.216.017.416.716.0 
Return on equity %22.122.425.224.423.4 
Return on capital %32.333.237.436.836.3 
Exports to sales %0.40.70.60.50.6 
Imports to sales %7.910.715.99.912.6 
Exports (fob) Rs m59120141122162 
Imports (cif) Rs m1,1761,7643,6592,2643,322 
Fx inflow Rs m113179240215268 
Fx outflow Rs m1,5172,1174,0412,7373,927 
Net fx Rs m-1,404-1,937-3,801-2,523-3,659 
ABBOTT INDIA CASH FLOW
From Operations Rs m 241 1,014 1,545 2,148 2,514 
From Investments Rs m 51 -585 -1,431 -1,867 -800 
From Financial Activity Rs m -420 -420 -424 -576 -803 
Net Cashflow Rs m -129 8 -309 -295 912 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 75.0%
Indian inst/Mut Fund 7.9%
FIIs 0.1%
ADR/GDR 0.0%
Free float 17.1%
Shareholders 18,270
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 3-4, Corporate Park, Sion Trombay Road, Mumbai - 400 071
E-MAIL investor.relations@abbott.co.in WEB www.abbott.co.in
TELEPHONE (022) 6797 8888 FAX (022) 6797 8727
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Sharepro Serv., 13 AB, Samhita Warehousing, 2nd Flr, Andheri (E), Mumbai-72
AUDITOR Deloitte Haskins & Sells
CHM: Munir Shaikh COMP SEC: Krupa Anandpara YEAR OF INC: 1944 BSE CODE: 500488 FV (Rs): 10 DIV YIELD (%): 0.8

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA  PLETHICO PHARMA  J.B.CHEMICALS  UNICHEM LAB  PFIZER  

Compare ABBOTT INDIA With:   SUN PHARMA  PLETHICO PHARMA  J.B.CHEMICALS  UNICHEM LAB  PFIZER  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trims Early Gains to Finish Flat; Indigo Slips 2.3%(Closing)

Indian share markets trimmed its early gains in the afternoon session to finish just above the dotted line amid mixed global cues.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

The 'Multibagger IPOs' You Should Be Betting On(The 5 Minute Wrapup)

Jun 22, 2017

Multibagger IPOs are few and far between. Here's how to spot them...

After Farm Loans, Will Govts Waive Off Mudra Loans Next?(Vivek Kaul's Diary)

Jun 19, 2017

If borrowers organise themselves and ask the government to waive off their loans, the government will find it very difficult to say no, having already established a precedent.

Get Ready for Commodity Options!(Daily Profit Hunter)

Jun 16, 2017

Commodity options trading is one step closer to reality. Learn how to take advantage of this tremendous opportunity.

Walter Schloss' Investing Record(Chart Of The Day)

Jun 17, 2017

In a market full of one-hit-wonders, this investor obviously had a formula that worked. And through the think-and-thin of the market.

11 Hidden Costs Associated With Your Home Loan(Outside View)

Jun 16, 2017

Various costs associated with a home loan.

More

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ABBOTT INDIA

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS